News

Media Center / News
The Pharmaceutical Sector, the Fourth Industrial Revolution, and the Future The Pharmaceutical Sector, the Fourth Industrial Revolution, and the Future

The Pharmaceutical Sector, the Fourth Industrial Revolution, and the Future

The first industrial revolution saw mechanization through water and steam power, the second saw mass production and assembly lines using electricity, the third adopted computers and automation, and the fourth is set to build on this further, with smart and autonomous systems fuelled by data and machine learning.

Digital Catch Up Digital Catch Up

Digital Catch Up

Alf Goebel looks at what the pharmaceutical sector needs to do to ensure it is fit for digital purpose and takes its place at the top of the digital maturity rankings rather than hiding away at the bottom.

How Can the Pharmaceutical Sector Reduce Its Carbon Footprint? How Can the Pharmaceutical Sector Reduce Its Carbon Footprint?

How Can the Pharmaceutical Sector Reduce Its Carbon Footprint?

For a sector that provides the medicines needed to keep people healthy, figures such as these which show the sector is actively harming the planet are shocking. However, we must remember that climate change is a threat to the future of humanity, with carbon dioxide emissions being the biggest contributor to a warming planet.

Covid Vaccination Serialization – The Journey So Far Covid Vaccination Serialization – The Journey So Far

Covid Vaccination Serialization – The Journey So Far

The global COVID pandemic has been one of the worst disasters we have collectively faced for generations, resulting in hundreds of thousands of deaths, disabilities, and losses of livelihoods.

Advanco and INEXTO forge track-and-trace partnership to combat counterfeiting Advanco and INEXTO forge track-and-trace partnership to combat counterfeiting

Advanco and INEXTO forge track-and-trace partnership to combat counterfeiting

In a major step forward in the ongoing battle against fake goods – some of which include counterfeit medicines that harm thousands of consumers each year – two of the world’s leading companies specialized in the fields of serialization and track-and-trace have joined together in a strategic partnership: advanco and INEXTO.

Building a future pandemic blueprint Building a future pandemic blueprint

Building a future pandemic blueprint

The ongoing Covid-19 pandemic has shone a spotlight on the vulnerability of the world in the face of a serious pandemic. On a human front, it has caused hundreds of thousands of deaths and has left people with life-changing disabilities and ongoing health problems. On an economic front, it has cost the globe multiple billions of dollars and has left people jobless and struggling to make ends meet.

Advanco is one of the “Top Supply Chain Management Solution Providers” in Europe 2021 Advanco is one of the “Top Supply Chain Management Solution Providers” in Europe 2021

Advanco is one of the “Top Supply Chain Management Solution Providers” in Europe 2021

The pharmaceutical industry has battled the presence of counterfeit products for some time now. It is estimated that some 10 per cent of pharma products worldwide are counterfeit, resulting in up to 1 million deaths per year.

Leaders in cross-industry serialization Leaders in cross-industry serialization

Leaders in cross-industry serialization

Regulatory compliance for serialisation is increasingly becoming a focus area for pharmaceutical manufacturers and supply chain partners across the world. Therefore, as would be expected, advanco is already well-known and solidly established within the pharmaceutical sector.

COVID-19 and Pharmaceutical Serialization: One Year Later COVID-19 and Pharmaceutical Serialization: One Year Later

COVID-19 and Pharmaceutical Serialization: One Year Later

Despite significant challenges caused by COVID-19 disruptions, the pharmaceutical track-and-trace sector has made strides in three areas to help secure the global supply chain now and well into the future.

What should the pharmaceutical serialisation sector be doing to protect against fake Covid-19 vaccines? What should the pharmaceutical serialisation sector be doing to protect against fake Covid-19 vaccines?

What should the pharmaceutical serialisation sector be doing to protect against fake Covid-19 vaccines?

The ongoing problem of counterfeit drugs has been brought to mainstream attention following the seizure of 3,000 saline-filled vials being sold as Covid-19 vaccines in China at the beginning of February 2021.

Chinese police seize over 3,000 fake COVID-19 vaccines Chinese police seize over 3,000 fake COVID-19 vaccines

Chinese police seize over 3,000 fake COVID-19 vaccines

Pharmaceutical counterfeiting brought to the fore, as more than 3,000 saline filled vials being sold as COVID-19 vaccines were seized in Chinese police raids.

Advanco and Syntegon Launch Strategic Serialization Partnership Advanco and Syntegon Launch Strategic Serialization Partnership

Advanco and Syntegon Launch Strategic Serialization Partnership

A strategic serialization partnership has been announced by advanco and Syntegon, aimed at tackling the global issue of counterfeit drugs.

Serialisation partnership announced to fight against counterfeit drugs Serialisation partnership announced to fight against counterfeit drugs

Serialisation partnership announced to fight against counterfeit drugs

Advanco and Syntegon have announced a strategic partnership, marking a significant step towards helping to eradicate the growing problem of counterfeit drugs. The counterfeit drug market is estimated to exceed $75Bn and is once again in the spotlight as the world searches for a COVID-19 vaccine.

Global demand for security of pharmaceutical and medical supplies post-COVID drives open standards Global demand for security of pharmaceutical and medical supplies post-COVID drives open standards

Global demand for security of pharmaceutical and medical supplies post-COVID drives open standards

Demand from governments and health organisations for greater assurances on the integrity and reliability of pharmaceutical and medical products to treat COVID-19 has prompted advanco, a leader in product serialization tracking software, to accelerate its plans for growth across global markets.

Q&A: The rise in counterfeit medicines during Covid-19 Q&A: The rise in counterfeit medicines during Covid-19

Q&A: The rise in counterfeit medicines during Covid-19

EPM speaks to Rami Cassis, executive chairman of pharmaceutical serialisation company Advanco and CEO of Parabellum Investments about the rise in counterfeit medicines during the Covid-19 pandemic.